Comparative Pharmacokinetic Assessment of Once-Daily Extended-Release and Twice-Daily Amantadine Formulations in Healthy Male Subjects Under Fasting Conditions. [PDF]
Kumar S +9 more
europepmc +1 more source
Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK). [PDF]
Rascol O +36 more
europepmc +1 more source
Deep learning, deeper relief: pipeline toward tailored analgesia for experimental animal models. [PDF]
Barleben L +9 more
europepmc +1 more source
Synthesis and Antileishmanial Activity of Cinnamic Acid-Amantadine Amides. [PDF]
Fernandes ÉB +17 more
europepmc +1 more source
A <i>meta</i>-analysis of the long-term efficacy of Amantadine for Levodopa-induced dyskinesia in Parkinson's disease. [PDF]
Williams K +3 more
europepmc +1 more source
Evaluation of neurotoxicity of drugs from morphological and electrophysiological endpoints using human iPSC-derived neural cell models. [PDF]
Qu Z +8 more
europepmc +1 more source
Bromocriptine, Selegiline and Amantadine in the Treatment of Depression-A Systematic Review. [PDF]
Bieś R +7 more
europepmc +1 more source
Non-competitive NMDA receptor antagonists moderate seizure-induced c-fos expression in the rat cerebral cortex [PDF]
Krisztin-Péva Beáta +5 more
core +1 more source

